Andreas Heinzel

Latest

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Synthetic lethality guiding selection of drug combinations in ovarian cancer
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft function
Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes
Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis
Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer
Predictive Biomarkers for Linking Disease Pathology and Drug Effect
Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer
Renal microRNA- and RNA-profiles in progressive chronic kidney disease
Molecular disease presentation in diabetic nephropathy
Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine
A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes
Protein interactome of muscle invasive bladder cancer
From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action
Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profiles
Functional molecular units for guiding biomarker panel design
Using information content for expanding human protein coding gene interaction networks
Molecular models of the cardiorenal syndrome
Data Graphs for Linking Clinical Phenotype and Molecular Feature Space
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy